Development of quality indicators for pregnancy and childbirth in patients with systemic lupus erythematosus-Reference-Cited by-同舟云学术

Development of quality indicators for pregnancy and childbirth in patients with systemic lupus erythematosus

Published:2024-04-08 Issue: Volume: Page:
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:

Author:

Hatano Mika¹^ORCID,Yajima Nobuyuki¹²³⁴^ORCID,Yanai Ryo¹,Ishii Sho¹,Tsujimoto Yasushi¹⁵⁶⁷,Azuma Teruhisa⁸,Atsumi Tatsuya⁹,Kaneko Yuko¹⁰,Kameda Hideto¹¹,Kuwana Masataka¹²,Tanaka Yoshiya¹³,Nakagawa Shiori¹⁴,Nakajima Ayako¹⁵,Hiramatsu Yuri¹⁶,Fujita Daisuke¹⁷,Miyamae Takako¹⁸,Murashima Atsuko¹⁹

Affiliation:

1. Division of Rheumatology, Department of Medicine, Showa University School of Medicine , Tokyo, Japan

2. Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine and Public Health , Kyoto, Japan

3. Department of Clinical Epidemiology, Fukushima Medical University , Fukushima City, Japan

4. Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University , Fukushima, Japan

5. Oku Medical Clinic , Osaka, Japan

6. Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto University , Kyoto, Japan

7. Scientific Research WorkS Peer Support Group (SRWS-PSG) , Osaka, Japan

8. Department of General Medicine, Nara Prefecture General Medical Center , Nara, Japan

9. Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University , Sapporo, Japan

10. Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine , Tokyo, Japan

11. Division of Rheumatology, Toho University , Tokyo, Japan

12. Department of Allergy and Rheumatology, Nippon Medical School , Tokyo, Japan

13. First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health , Fukuoka, Japan

14. Department of Nephrology and Laboratory Medicine, Kanazawa University , Kanazawa, Japan

15. Center for Rheumatic Diseases, Mie University Hospital , Mie, Japan

16. Department of Internal Medicine IV, Faculty of Medicine, Osaka Medical and Pharmaceutical University , Osaka, Japan

17. Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University , Osaka, Japan

18. Pediatric Rheumatology, Institute of Rheumatology, Tokyo Women’s Medical University , Tokyo, Japan

19. Japan Drug Information Institute in Pregnancy National Center for Child Health and Development , Tokyo, Japan

Abstract

ABSTRACT Objectives A quality indicator (QI) for the treatment of systemic lupus erythematosus (SLE) during pregnancy and childbirth that is useful for sharing standard treatment policies has not yet been developed. This study aimed to develop a QI for SLE associated with pregnancy and childbirth. Methods To identify candidate QIs, we conducted a systematic literature review on the development of QIs for SLE related to pregnancy and childbirth and on clinical practice guidelines. Candidate QI items were extracted from the final selected articles, and a first evaluation, panel meeting, and second evaluation were conducted to determine whether the candidate items were appropriate as QIs. Items for which all panel members reached a consensus were designated pregnancy and childbirth-related SLE QIs. Results Four articles on SLE QI development and 28 practice guidelines were listed through abstract/text screening. Based on these studies, 52 candidate QIs were extracted that were limited to items related to pregnancy and childbirth and 41 items were selected on which all panel members agreed. Conclusion We developed pregnancy-related SLE QIs using the RAND/UCLA method and selected 41 items, which could be used clinically.

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/mr/advance-article-pdf/doi/10.1093/mr/roae029/58937908/roae029.pdf

Reference42 articles.

1. Guidelines for Systemic Lupus Erythematosus (SLE);Japan College of Rheumatology

2. Treatment Guidelines for Pregnancy and Childbirth in Female Patients with Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA) and Inflammatory Bowel Disease (IBD) [Internet];Research Group for “Development of Treatment Guidelines for Pregnancy and Childbirth in Female Patients with Rheumatoid Arthritis (RA) and Inflammatory Bowel Disease (IBD)”

3. Research methods used in developing and applying quality indicators in primary care;Campbell;BMJ,2003

4. Defining quality of care;Campbell;Soc Sci Med,2000

5. A quality indicator set for systemic lupus erythematosus;Yazdany;Arthritis Rheum,2009